世界各国のリアルタイムなデータ・インテリジェンスで皆様をお手伝い
B型・C型肝炎診断薬の世界市場 2021-2025年Global Hepatitis B and C Diagnostics Market 2021-2025 B型肝炎・C型肝炎診断薬の世界市場 2021-2025年 Technavio社はB型・C型肝炎診断市場をモニターしており、予測期間中に6.22%のCAGRで進行し、2021年から2025年にかけて17.2億米ドルの成長が見込まれています。B型... もっと見る
日本語のページは自動翻訳を利用し作成しています。 
サマリーB型肝炎・C型肝炎診断薬の世界市場 2021-2025年Technavio社はB型・C型肝炎診断市場をモニターしており、予測期間中に6.22%のCAGRで進行し、2021年から2025年にかけて17.2億米ドルの成長が見込まれています。B型・C型肝炎診断市場に関する当レポートでは、全体的な分析、市場規模と予測、トレンド、成長要因、課題に加え、約25社のベンダーを網羅したベンダー分析も行っています。 本レポートでは、現在の世界市場のシナリオ、最新のトレンドとドライバー、そして市場全体の環境に関する最新の分析を提供しています。市場を牽引しているのは、HBVおよびHCVの診断における分子診断の需要の高まりと、POC診断の需要の高まりです。さらに、HBVとHCVの診断における分子診断の需要の高まりが、市場の成長をも後押しすると予想されます。 B型・C型肝炎診断市場の分析には、手順や疾患のセグメント、地理的な状況が含まれています。 TechnavioのB型・C型肝炎診断市場は以下のように区分されています。 地理的ランドスケープ別 - 北アメリカ - ヨーロッパ - アジア - ROW 手順別 - 免疫診断 - NAT 疾患別 - B型肝炎 - C型肝炎 本調査では、B型・C型肝炎診断市場の今後数年間の成長を促す主な要因の一つとして、診断プロセスの簡素化に向けた医療機関の戦略を挙げています。 Technavioは、複数の情報源から得たデータを調査、統合、主要なパラメータの分析によりまとめ、市場の詳細なイメージを提示しています。本レポートでは、B型およびC型肝炎の診断市場について、以下の領域を対象としています。 - B型肝炎・C型肝炎診断の市場サイジング - B型肝炎・C型肝炎診断市場の予測 - B型肝炎・C型肝炎診断市場の産業分析 Technavioの堅牢なベンダー分析は、クライアントの市場における地位向上を支援することを目的としており、本レポートではこれに沿って、B型・C型肝炎診断市場の主要ベンダーであるAbbott Laboratories、bioMerieux SA、Danaher Corp.、DiaSorin SpA、Enzo Biochem Inc.、F. Hoffmann-La Roche Ltd.、PerkinElmer Inc.、QIAGEN N.V、Quest Diagnostics Inc.、Siemens Healthineers AGなどの詳細な分析を行っています。また、B型・C型肝炎診断市場の分析レポートには、市場成長に影響を与える今後のトレンドや課題に関する情報も含まれています。これは、企業が戦略を練り、来るべき成長機会をすべて活用するためのものです。 本調査は、業界の主要参加者からの情報を含め、一次情報と二次情報を客観的に組み合わせて実施しました。本レポートには、主要ベンダーの分析に加えて、包括的な市場およびベンダーランドスケープが含まれています。このレポートの詳細については、- https://www.technavio.com/report/hepatitis-b-and-c-diagnostics-market-industry-analysis をご覧ください。 Technavio社は、複数の情報源から得たデータを調査、合成、要約し、利益、価格、競争、プロモーションなどの主要なパラメーターを分析することで、市場の詳細なイメージを提示しています。また、業界の主要なインフルエンサーを特定することで、様々な市場の側面を提示しています。提示されたデータは包括的で信頼性が高く、一次および二次両方の広範な調査の結果です。Technavio社の市場調査レポートは、正確な市場成長を予測するために、完全な競合状況と、質的・量的調査を用いた綿密なベンダー選択方法と分析を提供しています。 目次• Executive Summaryo Market Overview • Market Landscape o Market ecosystem o Value chain analysis • Market Sizing o Market definition o Market segment analysis o Market size 2020 o Market outlook: Forecast for 2020 - 2025 • Five Forces Analysis o Bargaining power of buyers o Bargaining power of suppliers o Threat of new entrants o Threat of substitutes o Threat of rivalry o Market condition • Market Segmentation by Procedure o Market segments o Comparison by Procedure o Immunodiagnostics - Market size and forecast 2020-2025 o NAT - Market size and forecast 2020-2025 o Market opportunity by Procedure • Market Segmentation by Diseases o Market segments o Comparison by Diseases o Hepatitis B - Market size and forecast 2020-2025 o Hepatitis C - Market size and forecast 2020-2025 o Market opportunity by Diseases • Geographic Landscape o Geographic segmentation o Geographic comparison o North America - Market size and forecast 2020-2025 o Europe - Market size and forecast 2020-2025 o Asia - Market size and forecast 2020-2025 o ROW - Market size and forecast 2020-2025 o Key leading countries o Market opportunity By Geographical Landscape o Market drivers o Market challenges o Market trends • Vendor Landscape o Overview o Vendor landscape o Landscape disruption • Vendor Analysis o Vendors covered o Market positioning of vendors o Abbott Laboratories o bioMerieux SA o Danaher Corp. o DiaSorin SpA o Enzo Biochem Inc. o F. Hoffmann-La Roche Ltd. o PerkinElmer Inc. o QIAGEN N.V o Quest Diagnostics Inc. o Siemens Healthineers AG • Appendix o Scope of the report o Currency conversion rates for US$ o Research methodology o List of abbreviations Exhibits • 1: Key Finding 1 • 2: Key Finding 2 • 3: Key Finding 3 • 4: Key Finding 5 • 5: Key Finding 6 • 6: Key Finding 7 • 7: Key Finding 8 • 8: Key Finding 9 • 9: Parent market • 10: Market characteristics • 11: Offerings of vendors included in the market definition • 12: Market segments • 13: Global - Market size and forecast 2020 - 2025 ($ million) • 14: Global market: Year-over-year growth 2020 - 2025 (%) • 15: Five forces analysis 2020 & 2025 • 16: Bargaining power of buyers • 17: Bargaining power of suppliers • 18: Threat of new entrants • 19: Threat of substitutes • 20: Threat of rivalry • 21: Market condition - Five forces 2020 • 22: Procedure - Market share 2020-2025 (%) • 23: Comparison by Procedure • 24: Immunodiagnostics - Market size and forecast 2020-2025 ($ million) • 25: Immunodiagnostics - Year-over-year growth 2020-2025 (%) • 26: NAT - Market size and forecast 2020-2025 ($ million) • 27: NAT - Year-over-year growth 2020-2025 (%) • 28: Market opportunity by Procedure • 29: Diseases - Market share 2020-2025 (%) • 30: Comparison by Diseases • 31: Hepatitis B - Market size and forecast 2020-2025 ($ million) • 32: Hepatitis B - Year-over-year growth 2020-2025 (%) • 33: Hepatitis C - Market size and forecast 2020-2025 ($ million) • 34: Hepatitis C - Year-over-year growth 2020-2025 (%) • 35: Market opportunity by Diseases • 36: Customer landscape • 37: Market share By Geographical Landscape 2020-2025 (%) • 38: Geographic comparison • 39: North America - Market size and forecast 2020-2025 ($ million) • 40: North America - Year-over-year growth 2020-2025 (%) • 41: Europe - Market size and forecast 2020-2025 ($ million) • 42: Europe - Year-over-year growth 2020-2025 (%) • 43: Asia - Market size and forecast 2020-2025 ($ million) • 44: Asia - Year-over-year growth 2020-2025 (%) • 45: ROW - Market size and forecast 2020-2025 ($ million) • 46: ROW - Year-over-year growth 2020-2025 (%) • 47: Key leading countries • 48: Market opportunity By Geographical Landscape ($ million) • 49: Impact of drivers and challenges • 50: Vendor landscape • 51: Landscape disruption • 52: Industry risks • 53: Vendors covered • 54: Market positioning of vendors • 55: Abbott Laboratories - Overview • 56: Abbott Laboratories - Business segments • 57: Abbott Laboratories - Key offerings • 58: Abbott Laboratories - Key customers • 59: Abbott Laboratories - Segment focus • 60: bioMerieux SA - Overview • 61: bioMerieux SA - Product and service • 62: bioMerieux SA - Key offerings • 63: bioMerieux SA - Key customers • 64: bioMerieux SA - Segment focus • 65: Danaher Corp. - Overview • 66: Danaher Corp. - Business segments • 67: Danaher Corp. - Key offerings • 68: Danaher Corp. - Key customers • 69: Danaher Corp. - Segment focus • 70: DiaSorin SpA - Overview • 71: DiaSorin SpA - Business segments • 72: DiaSorin SpA - Key offerings • 73: DiaSorin SpA - Key customers • 74: DiaSorin SpA - Segment focus • 75: Enzo Biochem Inc. - Overview • 76: Enzo Biochem Inc. - Business segments • 77: Enzo Biochem Inc. - Key offerings • 78: Enzo Biochem Inc. - Key customers • 79: Enzo Biochem Inc. - Segment focus • 80: F. Hoffmann-La Roche Ltd. - Overview • 81: F. Hoffmann-La Roche Ltd. - Business segments • 82: F. Hoffmann-La Roche Ltd. - Key offerings • 83: F. Hoffmann-La Roche Ltd. - Key customers • 84: F. Hoffmann-La Roche Ltd. - Segment focus • 85: PerkinElmer Inc. - Overview • 86: PerkinElmer Inc. - Business segments • 87: PerkinElmer Inc. - Key offerings • 88: PerkinElmer Inc. - Key customers • 89: PerkinElmer Inc. - Segment focus • 90: QIAGEN N.V - Overview • 91: QIAGEN N.V - Product and service • 92: QIAGEN N.V - Key offerings • 93: QIAGEN N.V - Key customers • 94: QIAGEN N.V - Segment focus • 95: Quest Diagnostics Inc. - Overview • 96: Quest Diagnostics Inc. - Business segments • 97: Quest Diagnostics Inc. - Key offerings • 98: Quest Diagnostics Inc. - Key customers • 99: Quest Diagnostics Inc. - Segment focus • 100: Siemens Healthineers AG - Overview • 101: Siemens Healthineers AG - Business segments • 102: Siemens Healthineers AG - Key offerings • 103: Siemens Healthineers AG - Key customers • 104: Siemens Healthineers AG - Segment focus • 105: Currency conversion rates for US$ • 106: Research Methodology • 107: Validation techniques employed for market sizing • 108: Information sources • 109: List of abbreviations
SummaryGlobal Hepatitis B and C Diagnostics Market 2021-2025 Table of Contents• Executive Summaryo Market Overview • Market Landscape o Market ecosystem o Value chain analysis • Market Sizing o Market definition o Market segment analysis o Market size 2020 o Market outlook: Forecast for 2020 - 2025 • Five Forces Analysis o Bargaining power of buyers o Bargaining power of suppliers o Threat of new entrants o Threat of substitutes o Threat of rivalry o Market condition • Market Segmentation by Procedure o Market segments o Comparison by Procedure o Immunodiagnostics - Market size and forecast 2020-2025 o NAT - Market size and forecast 2020-2025 o Market opportunity by Procedure • Market Segmentation by Diseases o Market segments o Comparison by Diseases o Hepatitis B - Market size and forecast 2020-2025 o Hepatitis C - Market size and forecast 2020-2025 o Market opportunity by Diseases • Geographic Landscape o Geographic segmentation o Geographic comparison o North America - Market size and forecast 2020-2025 o Europe - Market size and forecast 2020-2025 o Asia - Market size and forecast 2020-2025 o ROW - Market size and forecast 2020-2025 o Key leading countries o Market opportunity By Geographical Landscape o Market drivers o Market challenges o Market trends • Vendor Landscape o Overview o Vendor landscape o Landscape disruption • Vendor Analysis o Vendors covered o Market positioning of vendors o Abbott Laboratories o bioMerieux SA o Danaher Corp. o DiaSorin SpA o Enzo Biochem Inc. o F. Hoffmann-La Roche Ltd. o PerkinElmer Inc. o QIAGEN N.V o Quest Diagnostics Inc. o Siemens Healthineers AG • Appendix o Scope of the report o Currency conversion rates for US$ o Research methodology o List of abbreviations Exhibits • 1: Key Finding 1 • 2: Key Finding 2 • 3: Key Finding 3 • 4: Key Finding 5 • 5: Key Finding 6 • 6: Key Finding 7 • 7: Key Finding 8 • 8: Key Finding 9 • 9: Parent market • 10: Market characteristics • 11: Offerings of vendors included in the market definition • 12: Market segments • 13: Global - Market size and forecast 2020 - 2025 ($ million) • 14: Global market: Year-over-year growth 2020 - 2025 (%) • 15: Five forces analysis 2020 & 2025 • 16: Bargaining power of buyers • 17: Bargaining power of suppliers • 18: Threat of new entrants • 19: Threat of substitutes • 20: Threat of rivalry • 21: Market condition - Five forces 2020 • 22: Procedure - Market share 2020-2025 (%) • 23: Comparison by Procedure • 24: Immunodiagnostics - Market size and forecast 2020-2025 ($ million) • 25: Immunodiagnostics - Year-over-year growth 2020-2025 (%) • 26: NAT - Market size and forecast 2020-2025 ($ million) • 27: NAT - Year-over-year growth 2020-2025 (%) • 28: Market opportunity by Procedure • 29: Diseases - Market share 2020-2025 (%) • 30: Comparison by Diseases • 31: Hepatitis B - Market size and forecast 2020-2025 ($ million) • 32: Hepatitis B - Year-over-year growth 2020-2025 (%) • 33: Hepatitis C - Market size and forecast 2020-2025 ($ million) • 34: Hepatitis C - Year-over-year growth 2020-2025 (%) • 35: Market opportunity by Diseases • 36: Customer landscape • 37: Market share By Geographical Landscape 2020-2025 (%) • 38: Geographic comparison • 39: North America - Market size and forecast 2020-2025 ($ million) • 40: North America - Year-over-year growth 2020-2025 (%) • 41: Europe - Market size and forecast 2020-2025 ($ million) • 42: Europe - Year-over-year growth 2020-2025 (%) • 43: Asia - Market size and forecast 2020-2025 ($ million) • 44: Asia - Year-over-year growth 2020-2025 (%) • 45: ROW - Market size and forecast 2020-2025 ($ million) • 46: ROW - Year-over-year growth 2020-2025 (%) • 47: Key leading countries • 48: Market opportunity By Geographical Landscape ($ million) • 49: Impact of drivers and challenges • 50: Vendor landscape • 51: Landscape disruption • 52: Industry risks • 53: Vendors covered • 54: Market positioning of vendors • 55: Abbott Laboratories - Overview • 56: Abbott Laboratories - Business segments • 57: Abbott Laboratories - Key offerings • 58: Abbott Laboratories - Key customers • 59: Abbott Laboratories - Segment focus • 60: bioMerieux SA - Overview • 61: bioMerieux SA - Product and service • 62: bioMerieux SA - Key offerings • 63: bioMerieux SA - Key customers • 64: bioMerieux SA - Segment focus • 65: Danaher Corp. - Overview • 66: Danaher Corp. - Business segments • 67: Danaher Corp. - Key offerings • 68: Danaher Corp. - Key customers • 69: Danaher Corp. - Segment focus • 70: DiaSorin SpA - Overview • 71: DiaSorin SpA - Business segments • 72: DiaSorin SpA - Key offerings • 73: DiaSorin SpA - Key customers • 74: DiaSorin SpA - Segment focus • 75: Enzo Biochem Inc. - Overview • 76: Enzo Biochem Inc. - Business segments • 77: Enzo Biochem Inc. - Key offerings • 78: Enzo Biochem Inc. - Key customers • 79: Enzo Biochem Inc. - Segment focus • 80: F. Hoffmann-La Roche Ltd. - Overview • 81: F. Hoffmann-La Roche Ltd. - Business segments • 82: F. Hoffmann-La Roche Ltd. - Key offerings • 83: F. Hoffmann-La Roche Ltd. - Key customers • 84: F. Hoffmann-La Roche Ltd. - Segment focus • 85: PerkinElmer Inc. - Overview • 86: PerkinElmer Inc. - Business segments • 87: PerkinElmer Inc. - Key offerings • 88: PerkinElmer Inc. - Key customers • 89: PerkinElmer Inc. - Segment focus • 90: QIAGEN N.V - Overview • 91: QIAGEN N.V - Product and service • 92: QIAGEN N.V - Key offerings • 93: QIAGEN N.V - Key customers • 94: QIAGEN N.V - Segment focus • 95: Quest Diagnostics Inc. - Overview • 96: Quest Diagnostics Inc. - Business segments • 97: Quest Diagnostics Inc. - Key offerings • 98: Quest Diagnostics Inc. - Key customers • 99: Quest Diagnostics Inc. - Segment focus • 100: Siemens Healthineers AG - Overview • 101: Siemens Healthineers AG - Business segments • 102: Siemens Healthineers AG - Key offerings • 103: Siemens Healthineers AG - Key customers • 104: Siemens Healthineers AG - Segment focus • 105: Currency conversion rates for US$ • 106: Research Methodology • 107: Validation techniques employed for market sizing • 108: Information sources • 109: List of abbreviations
ご注文は、お電話またはWEBから承ります。お見積もりの作成もお気軽にご相談ください。本レポートと同分野（診断薬）の最新刊レポート
TechNavio社の診断薬分野での最新刊レポート本レポートと同じKEY WORD（hepatitis）の最新刊レポートよくあるご質問TechNavio社はどのような調査会社ですか?テクナビオ(TechNavio)は英国ロンドンに本社をおく幅広い市場を調査対象とする調査会社インフィニティリサーチ社(Infiniti Research)の調査レポート出版部門です。データリソースはT... もっと見る 調査レポートの納品までの日数はどの程度ですか?在庫のあるものは速納となりますが、平均的には 3-４日と見て下さい。
注文の手続きはどのようになっていますか?1)お客様からの御問い合わせをいただきます。
お支払方法の方法はどのようになっていますか?納品と同時にデータリソース社よりお客様へ請求書（必要に応じて納品書も）を発送いたします。
データリソース社はどのような会社ですか?当社は、世界各国の主要調査会社・レポート出版社と提携し、世界各国の市場調査レポートや技術動向レポートなどを日本国内の企業・公官庁及び教育研究機関に提供しております。
|
